230 related articles for article (PubMed ID: 3035025)
1. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
Gomez CM; Richman DP
J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
[TBL] [Abstract][Full Text] [Related]
2. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
Corey AL; Richman DP; Agius MA; Wollmann RL
J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
[TBL] [Abstract][Full Text] [Related]
3. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody.
Agius MA; Richman DP
J Immunol; 1986 Oct; 137(7):2195-8. PubMed ID: 3489757
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
Agius MA; Geannopoulos CJ; Fairclough RH; Richman DP
J Immunol; 1988 Jan; 140(1):62-8. PubMed ID: 3257231
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of myasthenia gravis.
Hughes BW; Moro De Casillas ML; Kaminski HJ
Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
[TBL] [Abstract][Full Text] [Related]
6. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
Burres SA; Crayton JW; Gomez CM; Richman DP
Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
[TBL] [Abstract][Full Text] [Related]
8. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
9. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
10. The role of acetylcholine receptor antibodies in myasthenia gravis.
Appel SH; Elias SB; Chauvin P
Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
[TBL] [Abstract][Full Text] [Related]
11. Passive transfer of seronegative myasthenia gravis to mice.
Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
Kelly JJ; Lambert EH; Lennon VA
Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
[TBL] [Abstract][Full Text] [Related]
13. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
Biesecker G; Koffler D
J Immunol; 1988 May; 140(10):3406-10. PubMed ID: 3258882
[TBL] [Abstract][Full Text] [Related]
14. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
Verschuuren JJ; Spaans F; De Baets MH
Muscle Nerve; 1990 Jun; 13(6):485-92. PubMed ID: 2366822
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
16. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
Tzartos SJ
In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
[TBL] [Abstract][Full Text] [Related]
17. Experimental models of myasthenia gravis: lessons in autoimmunity and progress toward better forms of treatment.
Pachner AR
Yale J Biol Med; 1987; 60(2):169-77. PubMed ID: 3495075
[TBL] [Abstract][Full Text] [Related]
18. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
[TBL] [Abstract][Full Text] [Related]
19. Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants.
Scadding GK; Calder L; Vincent A; Prior C; Wray D; Newsom-Davis J
Immunology; 1986 May; 58(1):151-5. PubMed ID: 3486818
[TBL] [Abstract][Full Text] [Related]
20. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]